Omeat
James Miller has held various leadership roles in the biopharmaceutical and healthcare industry, including serving as Chief Technology Officer at Omeat, Vice President Bioprocess Manufacturing at Resilience, Program Director/Project Manager at Genzyme, and Senior Manufacturing & Engineering Manager at Baxter Healthcare. Prior to their corporate career, James also served in the US Navy as a Petty Officer Second Class. Throughout their career, James has demonstrated expertise in operations, engineering, and project management.
This person is not in any teams
Omeat
Omeat is a food startup that has pioneered a scalable way to produce cultivated meat that’s delicious, affordable, orders-of-magnitude more sustainable than conventional meat, and doesn’t involve sacrificing an animal. The secret to Omeat is a proprietary process that harnesses the intrinsically regenerative factors within cows' plasma to foster cell growth. Omeat’s growth media is a cost-effective alternative to fetal bovine serum and can be used to cultivate any kind of meat. Omeat is based in Los Angeles, founded in 2020 by world-renown tissue biologist Dr. Ali Khademhosseini. The company is currently building a pilot plant and rapidly expanding its team toward commercial readiness.